Elizabeth Atchison, MD
Ophthalmology · Sioux Falls, SDNPI 1669738183
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Alimera Sciences, Inc. at 48.6% of the total. Reporting peaked in 2024 at $675 and has fallen 50.9% since, to $331 in 2025.
Across 59 payments — averaging $38.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alimera Sciences, Inc.$1K
- AbbVie$314
- Apellis Pharmaceuticals, Inc.$180
- Amgen$97
- Dutch Ophthalmic, USA$84
- Regeneron Healthcare Solutions, Inc.$77
- plus $421 from 17 others
What the payments were for
- Food & beverage$2,26399%
- Gifts$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alimera Sciences, Inc. | 9 | $1,110 |
| AbbVie(2 entities) | 12 | $314 |
| Apellis Pharmaceuticals, Inc. | 4 | $180 |
| Amgen(2 entities) | 6 | $97 |
| Dutch Ophthalmic, USA | 1 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Genentech USA, Inc. | 4 | $57 |
| Bausch & Lomb Americas Inc. | 3 | $53 |
| Astellas Pharma US Inc | 2 | $38 |
| Coherus Oncology, Inc. | 2 | $31 |
| The Cameron-ehlen Group, Inc. | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| Alcon | 1 | $25 |
| Rxsight Inc | 1 | $25 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Eyepoint US, Inc. | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Spark Therapeutics, Inc. | 1 | $17 |
| Biogen | 1 | $16 |
| Harrow Eye, LLC | 1 | $14 |
| Sandoz | 1 | $14 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $12 |
| Aerie Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,282 in reported general payments places this provider in the 70th percentile of 52 ophthalmology providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 136 | $6,820 |
| Atropine Sulfate | 82 | $2,568 |
| Ketorolac Tromethamine | 33 | $969 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 91 | $592 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 17 | $293 |
| Latanoprost | 17 | $193 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Sioux Falls
- Vance ThompsonSioux Falls$1.9M
- John BerdahlSioux Falls$1.2M
- Daniel TerveenSioux Falls$521K
- Tanner FergusonSioux Falls$49K
- Alison TendlerSioux Falls$31K
- Brent KramerSioux Falls$26K
- Jed AssamSioux Falls$18K
- Anthony MaiSioux Falls$8K
- Ryan GeraetsSioux Falls$7K
- Eric ThomasSioux Falls$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.